The global nasal spray market growth is anticipated to progress at a CAGR of 9.39% during the forecast period, 2021-2028

The increasing intranasal vaccines for COVID-19, growing adoption of nasal sprays due to easy administration methods, and rising acceptance in self-medication propel market growth. MARKET INSIGHTS

New York, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLOBAL NASAL SPRAY MARKET FORECAST 2021-2028" - https://www.reportlinker.com/p05758928/?utm_source=GNW
Nasal sprays are used to treat allergies, sinus infections, and congestion.There is an increasing number of allergy cases in western countries.

Also, as per the World Allergy Organization, more than 400 million have allergic rhinitis (AR) across the world.
The COVID-19 pandemic, due to its contagious nature, has sped up vaccination trials across the globe.The nasal route is evaluated to have significant potential for vaccination, given the organized immune systems of the nasal mucosa.

Also, nasal delivery has several benefits over the traditional approaches to vaccine administration, such as ease of administration without needles.As a result, several companies are manufacturing nasal spray vaccines.

In an independent clinical trial, Amcyte Pharma’s Nasitrol nasal spray was found to be effective in reducing COVID-19 infections among ICU (Intensive Care Unit) staff.Such factors facilitate growth.

However, the risks associated with the overuse of nasal sprays hamper the market growth.

REGIONAL INSIGHTS
The global nasal spray market growth assessment includes the analysis of Europe, North America, Asia-Pacific, and Rest of World. North America is the dominating region in terms of revenue share, accredited to breathing problems in the region caused by chronic obstructive pulmonary disease (COPD).

COMPETITIVE INSIGHTS
The competitive rivalry in the market is characterized by companies offering unique products and thereby harboring a major share in that specific target products. GlaxoSmithKline Plc, Novartis International AG, Pfizer Inc, Johnson & Johnson, etc., are among the key companies in the market.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. AKORN INCORPORATED
2. ALLERGAN PLC
3. APOTEX INC
4. BHARAT BIOTECH
5. CATALENT INC
6. CIPLA LIMITED
7. GLAXOSMITHKLINE PLC
8. JOHNSON & JOHNSON
9. NOVARTIS INTERNATIONAL AG
10. PFIZER INC
11. PROCTOR & GAMBLE CO (P&G)
12. SANOTIZE RESEARCH AND DEVELOPMENT
13. SUN PHARMACEUTICALS INDUSTRIES LTD
14. TEVA PHARMACEUTICALS INDUSTRIES LTD
15. VIATRIS
Read the full report: https://www.reportlinker.com/p05758928/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001